Based on the significant attenuation of liver fibrosis in NASH mice with EC-specific knockout of Mlkl, we sought to define the molecular mechanisms underlying the anti-fibrotic effect of MlkliΔEC/iΔEC mice. The gene discussed is MLKL; the disease is metabolic dysfunction-associated steatohepatitis.